Abstract:BackgroundWhether extended lymphadenectomy for right colon cancer leads to increased perioperative complications or improves survival is still controversial. This trial aimed to compare the efficacy and safety of complete mesocolic excision (CME) versus D2 dissection in laparoscopic right hemicolectomy for patients with right colon cancer. This article reports the early safety results from the trial.MethodsThis randomised, controlled, phase 3, superiority, trial was done at 17 hospitals in nine provinces of China. Eligible patients were aged 18–75 years with histologically confirmed primary adenocarcinoma located between the caecum and the right third of the transverse colon, without evidence of distant metastases. Central randomisation was done by means of the Clinical Information Management-Central Randomisation System via block randomisation (block size of four). Patients were randomly assigned (1:1) to CME or D2 dissection during laparoscopic right colectomy. Central lymph nodes were dissected in the CME but not in the D2 procedure. Neither investigators nor patients were masked to their group assignment but the quality control committee were masked to group assignment. The primary endpoint was 3-year disease-free survival, but the data for this endpoint are not yet mature; thus, only the secondary outcomes—intraoperative surgical complications and postoperative complications within 30 days of surgery, graded according to the Clavien-Dindo classification, mortality (death from any cause within 30 days of surgery), and central lymph node metastasis rate in the CME group only—are reported in this Article. This early analysis of safety was preplanned. The outcomes were analysed according to a modified intention-to-treat principle (excluding patients who no longer met inclusion criteria after surgery or who did not have surgery). This study is registered with ClinicalTrials.gov, NCT02619942. Study recruitment is complete, and follow-up is ongoing.FindingsBetween Jan 11, 2016, and Dec 26, 2019, 1072 patients were enrolled and randomly assigned. After exclusion of 77 patients, 995 patients were included in the modified intention-to-treat population (495 in the CME group and 500 in the D2 dissection group). The postoperative surgical complication rate was 20% (97 of 495 patients) in the CME group versus 22% (109 of 500 patients) in the D2 group (difference, −2·2% [95% CI −7·2 to 2·8]; p=0·39); the frequency of Clavien-Dindo grade I–II complications were similar between groups (91 [18%] vs 92 [18%], difference, −0·0% [95% CI −4·8 to 4·8]; p=1·0) but Clavien-Dindo grade III−IV complications were significantly less frequent in the CME group than in the D2 group (six [1%] vs 17 [3%], −2·2% [−4·1 to −0·3]; p=0·022); no deaths occurred in either group. Of the intraoperative complications, vascular injury was significantly more common in the CME group than in the D2 group (15 [3%] vs six [1%], difference, 1·8 [95% CI 0·04 to 3·6]; p=0·045). Metastases in the central lymph nodes were detected in 13 (3%) of 394 patients who underwent central lymph node biopsy in the CME group; no patient had isolated metastases to central lymph nodes.InterpretationAlthough the CME procedure might increase the risk of intraoperative vascular injury, it generally seems to be safe and feasible for experienced surgeons.FundingThe Capital Characteristic Clinical Project of Beijing and the Chinese Academy of Medical Sciences.

Right thoracal and upper abdominal incisions for the treatment of mid-esophageal cancer

[Apico-Thoracic Retro-Aortic Anastomosis in Radical Operation for Esophageal Carcinoma].

Dual-incision of Left Neck and Chest Esophagectomy of Esophageal Carcinoma of Middle and Upper Segments in Chest

Radical Correction Through Right Chest and Middle of Upper Abdomen for Esophageal Cancer

[Comparison of Surgical Outcomes after Different Surgical Approach for Middle or Lower Thoracic Esophageal Squamous Cancer].

A Comparison of Different Surgical Approaches for the Treatment of Thoracic Middle/lower Segment Esophageal Cancer

Cervical Anastomosis by Thoracic Approach for the Treatment of Upper Esophageal Cancer

Short-term Outcomes of Complete Mesocolic Excision Versus D2 Dissection in Patients Undergoing Laparoscopic Colectomy for Right Colon Cancer (RELARC): a Randomised, Controlled, Phase 3, Superiority Trial

Application of the Anastomosis above Chest Top in Upper or Middle Esophagectomy

Surgical Treatment of the Cervical and Upper Thoracic Esophageal Carcinoma

[Video-Assisted Thoracoscopic Esophagectomy for Esophageal Carcinoma and Gastro-Esophageal Anastomosis in Thoracic Cavity: Analysis of 60 Cases].

Clinical Analysis of Lymphadenectomy in Patients with Esophageal Carcinoma Underwent Single Left Thoracal Incision and Cervico-Right Thoracic-Abdominal Triple Incision

Ten-year Survivals of Right Thoracic Versus Left Thoracic Approach for Esophageal Cancer

Ten-Year Survivals of Right Thoracic vs Left Thoracic Approach for Esophageal Cancer

Treatment of Early-Stage Upper And/or Middle Thoracic Esophageal Cancer with a New Muscle-Sparing Thoracotomy

Efficacy and Safety of Esophagectomy Via Left Thoracic Approach Versus Via Right Thoracic Approach for Middle and Lower Thoracic Esophageal Cancer: a Multicenter Randomized Clinical Trial (NST1501)

A Retrospective Study of Short-Term Outcomes of Minimally Invasive Ivor-Lewis Esophagectomy and McKeown Esophagectomy for Thoracic Middle-Lower Esophageal Carcinoma

Short-Term and Long-Term Outcomes Following Transhiatal Versus Right Thoracoabdominal Resection of Siewert Type II Adenocarcinoma of the Esophagogastric Junction

Extended Right Thoracic Approach Compared with Limited Left Thoracic Approach for Patients with Middle and Lower Esophageal Squamous Cell Carcinoma Three-year Survival of a Prospective, Randomized, Open-label Trial

Minimally Invasive Esophageal Resection and Intrathoracic Anastomosis for Lower Thoracic Esophageal Cancer with Single Position.

Thoracoscopic and Laparoscopic Esophagectomy Versus Open Procedure for Early Stage Esophageal Carcinoma:Comparison of Clinical Outcomes